Pathology And Its Related Factors Impacting Prognoses Of Borderline Ovarian Tumors

Objective:To investigate the clinical features of Ovarian Tumor Borderline (BOT) and the factors affecting its prognosis.Methods:a retrospective analysis in 2003 January to June 2014 in Affiliated Tumor Hospital of Xinjiang Medical University Department of gynaecology treatment of 88 cases of benign ovarian tumor patients in general at the junction of, pathology, clinical treatment and prognosis and prognostic factors of evaluation. Results:(1) the BOT occur in women of childbearing age, the average patient age was 42.3±14.5 years of age, ovarian borderline serous tumor (Serous borderline ovarian tumor, sbot), ovary borderline mucinous tumor (Mucinous borderline ovarian tumor, our), at the junction of endometrial tumor like and mixed ovarian at the junction of the proportion of tumor was 38.64%,55.68% and 3.41% and 2.27%. (2) the levels of serum tumor markers CA199 and CA125 were 98.95 and 47.73%, respectively, and the average level was 40.91%±39.52 and 93.15±40.42IU/mL respectively. (3) the average diameter of tumor was 15.24±8.62cm, the diameter of SBOT tumor was 10.85±6.13cm, the diameter of MBOT tumor was 18.38±9.76cm. There were 82.95% lesions in patients with unilateral ovarian,17.05% lesions in patients with bilateral ovarian, sbot unilateral ovarian lesions in 24 cases (70.59%), bilateral ovarian lesions in 4 cases, accounting for 29.41%, our unilateral ovarian lesions in 45 cases of 91.84%, involving bilateral ovarian lesions in 10 cases of 8.16%,88 samples of 21.59% patients appeared micro invasive, 12.5% associated with peritoneal seeding, but there were no lymph node metastasis. (4) the proportion of I stage, II stage and III stage of the FIGO stage was 79.55%,17.05%and 5.68% respectively..82.95% patients underwent laparotomy, otherwise 17.05% patients received laparoscopic surgery,59.09% patients received comprehensive surgical staging, 40.91% patients chose to fertility sparing surgery for,38.64% of patients after operation undergoing chemotherapy. Recurrence occurred during follow-up of 3.41% patients during the follow-up period.. (5) single factor analysis of variance showed:tumor FIGO stage, micro invasion, peritoneal metastasis and prognosis; logistic analysis showed that tumor FIGO staging low better outcomes for patients treated, and micro invasion and peritoneal implants were on ovarian junction and prognosis of the tumor effect.Conclusion:borderline ovarian tumor in women of childbearing age, pathological classification sbot, our main; serum tumor markers CA125 and CA199 is for diagnosis of ovarian borderline tumor meaning little; borderline ovarian tumor patients with unilateral lesions; rare cases of patients with tumor invasion and peritoneal seeding; borderline ovarian tumor patients with FIGO stage Ⅰ; high FIGO stage, micro invasive and peritoneal seeding is prognostic risk factors.